National brain tumour research funding needs to increase to £35 million a year
Raising awareness of GBM
Glioblastoma multiforme (GBM) is the most common, complex, treatment-resistant and deadliest type of brain cancer.
We are holding our first GBM Awareness Week, shining a spotlight on this type of brain tumour to coincide with GBM Awareness Day on Wednesday.
We are sharing the powerful stories of brave supporters who are highlighting the devastation of a GBM diagnosis. We’re sharing the hope that lies in the cutting-edge research we are funding at our Centres of Excellence. And we’re asking you to support us by donating to help find a cure not just for GBM, but for all types of brain tumour.
To help lift the lid on GBM, here are five things you should know:
- GBM is the most common type of primary high-grade brain tumour in adults.
- The average survival time following a GBM diagnosis is devastatingly short – just 12-18 months. Only 25% of GBM patients survive more than one year and just 5% survive more than five years.
- The diffuse nature of this type of the disease means tumour cells invade healthy areas of the brain. Even after debulking the tumour with surgery, some cells will almost always be left behind and will continue to grow.
- Treatment options are very limited and there is no cure.
- Brain Tumour Research is funding research across our Centres of Excellence which is at the cutting edge of finding a cure
Visit our new GBM Awareness Week webpage to read the stories of supporters are sharing, learn more about the research to get us closer to a cure, and to donate to help us fund the fight against this devastating disease: https://www.braintumourresearch.org/info-support/raising-awareness-of-GBM
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.